Nagano, Japan

Kazuhiro Kosakai

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kotobuki Pharmaceutical Co Ltd. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Kosakai. Retrieved from https://idiyas.com/inventor/kazuhiro-kosakai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhiro Kosakai: Innovator in Cholesterol Management

Introduction

Kazuhiro Kosakai is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of medicine, particularly in the development of agents aimed at lowering serum cholesterol levels. His work is crucial in the fight against atherosclerosis, a condition that can lead to serious cardiovascular diseases.

Latest Patents

Kazuhiro Kosakai holds 1 patent for a serum cholesterol lowering agent or preventative or therapeutic agent for atherosclerosis. This innovative agent comprises a combination of a compound represented by a specific general formula and a cholesterol biosynthesis inhibitor and/or a fibrate type cholesterol lowering agent. The formula includes various groups and components that work together to effectively lower cholesterol levels in the serum.

Career Highlights

Throughout his career, Kazuhiro has been associated with Kotobuki Pharmaceutical Co. Ltd., where he has focused on research and development in pharmaceutical sciences. His dedication to improving health outcomes through innovative solutions has positioned him as a key figure in his field.

Collaborations

Kazuhiro has collaborated with esteemed colleagues such as Hiroshi Tomiyama and Masayuki Yokota. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kazuhiro Kosakai's contributions to cholesterol management through his innovative patent highlight his commitment to advancing medical science. His work continues to impact the field positively, offering hope for better health outcomes in patients with atherosclerosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…